Indivior secures FDA approval for Perseris to treat schizophrenia
Specialty pharmaceutical company Indivior has secured the US Food and Drug Administration (FDA) approval for...
Alkermes’ Aristada Initio approved by FDA for schizophrenia
Irish biopharmaceutical company Alkermes has received approval from the US Food and Drug Administration (FDA)...